Institutional Review Board Statement
The study was conducted following the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the Committee of Ethics in Research of the University Center of Maringá (UniCesumar) approved this study through opinion number 4.913.453/2021. After approval by the committee, the project was registered with the Brazilian Clinical Trials Registry Platform (ReBEC) under the number RBR-8fp63gm.